50 Years of Patient-Focused Innovations
THIS FALL, WE WRAP UP OUR CELEBRATION OF DUKE’S 50 YEARS of transforming cancer discovery and care as a comprehensive cancer center. This issue of Breakthroughs highlights how we have revolutionized the field of stem cell transplant and improved outcomes for people with blood cancers. This field has also set the stage for promising new cancer-fighting immunotherapies, and as we look to the future, we envision more patients benefiting from the ability to engineer cells to make them better cancer killers and to target them to each individual.
These are just a few of the innovations that you have made possible. You’ll also see featured in this issue a milestone approval of a new drug for advanced breast cancer, as well as one of our efforts to expand breast cancer care to our surrounding communities.
I want to thank you — our donors and friends — for your continued partnership. Your willingness to stand beside us in the fight against cancer motivates us to continue pushing boundaries to discover, develop, and deliver tomorrow’s cancer care...today.
Michael B. Kastan, MD, PhD
Executive Director, Duke Cancer Institute
Professor of Pediatrics
William and Jane Shingleton Professor, Pharmacology and Cancer Biology